These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36226781)

  • 1. Prescribing patterns and attitudes of primary care providers regarding long-term opioid therapy.
    Koch NV; Butterfield Iii RJ
    J Opioid Manag; 2022; 18(5):407-420. PubMed ID: 36226781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization.
    Kirane H; Drits E; Ahn S; Kapoor S; Morgenstern J; Conigliaro J; Enden J
    J Opioid Manag; 2019; 15(3):193-204. PubMed ID: 31343721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.
    Behar E; Rowe C; Santos GM; Coffa D; Turner C; Santos NC; Coffin PO
    J Gen Intern Med; 2017 Mar; 32(3):291-295. PubMed ID: 27815762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.
    Mueller SR; Koester S; Glanz JM; Gardner EM; Binswanger IA
    J Gen Intern Med; 2017 Mar; 32(3):277-283. PubMed ID: 27798775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs and attitudes about prescribing opioids among healthcare providers seeking continuing medical education.
    Hooten WM; Bruce BK
    J Opioid Manag; 2011; 7(6):417-24. PubMed ID: 22320023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and implementation of current opioids guideline among healthcare providers in Manitoba.
    Sanchez-Ramirez DC; Polimeni C
    J Opioid Manag; 2019; 15(1):27-34. PubMed ID: 30855720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.
    Jamison RN; Sheehan KA; Scanlan E; Matthews M; Ross EL
    J Opioid Manag; 2014; 10(6):375-82. PubMed ID: 25531955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine Waiver Attitudes Among Primary Care Providers.
    Lai B; Croghan I; Ebbert JO
    J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.
    Peckham AM; Niculete ME; Steinberg H; Boggs DL
    J Public Health Manag Pract; 2018; 24(4):310-317. PubMed ID: 29084123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid prescribing knowledge and practices: provider survey following promulgation of guidelines-Utah, 2011.
    Porucznik CA; Johnson EM; Rolfs RT; Sauer BC
    J Opioid Manag; 2013; 9(3):217-24. PubMed ID: 23771571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers.
    Starrels JL; Peyser D; Haughton L; Fox A; Merlin JS; Arnsten JH; Cunningham CO
    Subst Abus; 2016; 37(1):148-53. PubMed ID: 26860130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic family medicine physicians' confidence and comfort with opioid analgesic prescribing for patients with chronic nonmalignant pain.
    Macerollo AA; Mack DO; Oza R; Bennett IM; Wallace LS
    J Opioid Manag; 2014; 10(4):255-61. PubMed ID: 25162605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of Ontario primary care physicians' experiences with opioid prescribing.
    Wenghofer EF; Wilson L; Kahan M; Sheehan C; Srivastava A; Rubin A; Brathwaite J
    Can Fam Physician; 2011 Mar; 57(3):324-32. PubMed ID: 21402971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D.
    Strickland JC; Huhn AS; Bergeria CL; Strain EC; Dunn KE
    J Addict Med; 2021 Jul-Aug 01; 15(4):325-333. PubMed ID: 33156180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in opioid prescribing for chronic pain in Washington State.
    Franklin GM; Fulton-Kehoe D; Turner JA; Sullivan MD; Wickizer TM
    J Am Board Fam Med; 2013; 26(4):394-400. PubMed ID: 23833154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing?
    McCalmont JC; Jones KD; Bennett RM; Friend R
    J Opioid Manag; 2018; 14(2):103-116. PubMed ID: 29733096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid prescribing attitudes of palliative care physicians versus other specialists: a questionnaire-based survey.
    Dzierzanowski T; Kozlowski M
    Postgrad Med J; 2022 Feb; 98(1156):119-123. PubMed ID: 33414178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.